NCT07187843View on ClinicalTrials.gov

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

May 31, 2031

Conditions
Parkinson DiseaseParkinsonian DisordersBrain DiseaseBasal Ganglia DiseasesSynucleinopathies
Interventions
OTHER

Clinical assessments

standardized neurological examination, motor and non-motor symptom scales, cognitive testing, and autonomic symptom questionnaires.

OTHER

Phenotypic classification

patients will be stratified into Brain-First and Body-First phenotypes based on the presence of RBD and instrumental findings.

Trial Locations (1)

Unknown

RECRUITING

Azienda USL IRCCS di Reggio Emilia, Reggio Emilia

All Listed Sponsors
lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV